Endocrinology Presentations
Menopause and Andropause
David Morris has been an Associate Professor of Medicine and Gynecology at McGill since 1987. Before this he underwent a long training in Internal Medicine and Endocrinology having graduated originally from Cambridge University in 1970. He was involved in the development of pelvic ultrasonography for the diagnosis of female reproductive disorders. In Canada for 26 years with a primary responsibility in Reproductive Medicine. He helped found the McGill Reproductive Centre (now the MUHC Reproductive Centre). His major Research interest has been the relationship between metabolic disease and infertility in men and women (Polycystic Ovary Syndrome) and its treatment. Other areas include the treatment of Premature Ovarian Failure and the metabolic disturbances associated with malignant disease.
Learning Objectives:
- The perimenopause and its problems
- Clinical impacts of the early and normal menopause
- Management of estrogen deficiency or management of risk factors?
- Is the ‘Andropause’ real and what are the causes of hypogonadism in older men
- Management of hypogonadism in older men
Adrenal Update
Dr. Christopoulos completed her medical school training at Ï㽶ÊÓƵ followed by a residency in internal medicine and endocrinology in the same university. She then pursued a research and clinical fellowship at Université de Montréal in adrenal pathologies. Her fields of interest include diabetes and adrenal pathologies. She is currently a full-time staff in the division of endocrinology at the jewish General Hospital and an assistant professor of medicine at Ï㽶ÊÓƵ. She is very active in preclinical, clinical and continuing medical education.
Ìý
Learning Objectives:
- Have a practical approach to an adrenal incidentaloma
- Suspect and screen for Cushing’s syndrome
- Suspect and screen for adrenal insufficiency
- Have an approach to weaning off glucocorticoids
Diabetes Technology Update
Dr. Pasqua obtained her Bachelor of Science and Doctorate in Medicine from the University of Ottawa, followed by her residency training in internal medicine and endocrinology at Ï㽶ÊÓƵ. She started graduate studies during her endocrinology training in experimental medicine at McGill, for which she received FRQS funding for students with professional degrees. She is currently an endocrinologist at the MUHC.
Ìý
Ìý
Learning Objectives:
- Describe the benefits, evidence-base and indications for continuous glucose monitoring devices available in Canada
- Review the details of an ambulatory glucose profile and continuous glucose monitoring data based on international guidelines
- Appreciate the latest development in insulin pump therapy, and their clinical benefits
Interactive Type 2 Diabetes Cases
Ìý
Dr. Yale is a professor of endocrinology at the MUHC. He was a member of the steering committee for the Diabetes Canada guidelines from 1995 to 2019, and is engaged in clinical research on new therapies for type 1 and type 2 diabetes and on hypoglycemia.
Ìý
Ìý
Learning Objectives:
- As a result of attending this session, the participants will gain abilities in selecting appropriate antihyperglycemic therapies based on the patient’s clinical characteristics
Type 2 Diabetes Update
Ìý
Dr. Yale is a professor of endocrinology at the MUHC. He was a member of the steering committee for the Diabetes Canada guidelines from 1995 to 2019, and is engaged in clinical research on new therapies for type 1 and type 2 diabetes and on hypoglycemia.
Ìý
Ìý
Learning Objectives:
- Describe the Diabetes Canada guidelines for cardio-renal protection in type 2 diabetes
- Compare the antihyperglycemic agents available in terms of efficacy to decrease A1c and weight and side effects
- Position the newer agents in the therapeutic strategy